A team led by Professor Kazuhiro Maeshima of the National Institute of Genetics (ROIS) and SOKENDAI in Japan has developed a ...

University of Pittsburgh researchers discovered that a mix of growth factors can rescue cells from late-stage anthrax damage ...

A study by Oregon Health & Science University researchers has uncovered a new way proteins can be changed inside cells. This ...

Scientists have taken an important step toward the development of a potential new treatment for treating Shiga ...

US FDA declines to approve Milestone's heart rhythm nasal spray; shares halve Milestone Pharmaceuticals said on Friday the U.S. health regulator had declined to approve its nasal spray to treat a ...

People who live near the historic Dawson Park in north Portland say police efforts to deal with criminal activity is only one addressing one of several issues with the park. Friends of Phoenix ...

LONDON, GB / ACCESS Newswire / March 31, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO), the biopharmaceutical group developing new therapies and treatments for blood diseases, announces that the ...

In the last three months, 4 analysts have published ratings on X4 Pharmaceuticals XFOR, offering a diverse range of perspectives from bullish to bearish. The following table encapsulates their ...

Ultragenyx Pharmaceutical (NASDAQ ... an antibody targeting fibroblast growth factor 23 for the treatment of X-linked hypophosphatemia, as well as tumor-induced osteomalacia; Mepsevii, an enzyme ...

In this episode of C&EN Uncovered, host Craig Bettenhausen speaks with C&EN assistant editor Laurel Oldach about the use of horseshoe crab blood in pharmaceutical endotoxin testing, the challenges of ...